World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
71
Citations
14972
World Ranking
2217
National Ranking
82

Karoly Szuhai publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Karoly Szuhai sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 251 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Karoly Szuhai D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Karoly Szuhai sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 71 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Karoly Szuhai is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions spanning related subfields including Molecular Biology, Rheumatology, Pulmonary and Respiratory Medicine, Oral Surgery, and Oncology.

The scientist has contributed extensively to topics such as Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Oral and Maxillofacial Pathology, Cancer Genomics and Diagnostics, CRISPR and Genetic Engineering, Soft tissue tumor case studies, and Epigenetics and DNA Methylation.

Karoly Szuhai's recent publications illustrate a focus on cancer biology, molecular pathology, and therapeutic resistance mechanisms. Notable papers include:

  • "Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma," 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  • "Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors," 2021, The American Journal of Surgical Pathology
  • "Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases," 2021, Modern Pathology
  • "Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma," 2020, Cancers
  • "Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches," 2022, Expert Opinion on Therapeutic Targets

Szuhai has frequently published in several scientific venues, most notably in:

  • The American Journal of Surgical Pathology
  • Cancers
  • Modern Pathology
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)

The researcher collaborates often with colleagues including Judith V.M.G. Bovée, Inge H. Briaire-de Bruijn, Arjen H.G. Cleven, Sheena L. M. Ong, and Hans J. Baelde.

Best Publications

  • Sarcoma derived from cultured mesenchymal stem cells

    Jakub Tolar;Alma J. Nauta;Mark J. Osborn;Angela Panoskaltsis Mortari

  • Chromosome Segregation Errors as a Cause of DNA Damage and Structural Chromosome Aberrations

    Aniek Janssen;Marja van der Burg;Karoly Szuhai;Geert J. P. L. Kops

  • Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

    Twinkal C. Pansuriya;Ronald van Eijk;Pio d'Adamo;Maayke A. J. H. van Ruler

  • The carcinoma–stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage

    Wilma E. Mesker;Jan M. C. Junggeburt;Karoly Szuhai;Pieter de Heer

  • Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples.

    Danielle M. de Jong;Sofie Lj Verbeke;Danielle Meijer;Pancras Cw Hogendoorn

  • Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.

    Alexander B Mohseny;Karoly Szuhai;Salvatore Romeo;Emilie P Buddingh

  • Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents

    Carla Rosenberg;Carla Rosenberg;J. Knijnenburg;E. Bakker;A. M. Vianna-Morgante

  • Oncogenomic analysis of mycosis fungoides reveals major differences with Sézary syndrome

    Remco van Doorn;Marloes S. van Kester;Remco Dijkman;Maarten H. Vermeer

  • Novel and highly recurrent chromosomal alterations in Sézary syndrome.

    Maarten H. Vermeer;Remco van Doorn;Remco Dijkman;Xin Mao

  • The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.

    Károly Szuhai;Marije IJszenga;Danielle de Jong;Apollon Karseladze

  • EWSR1-CREB1 and EWSR1-ATF1 Fusion Genes in Angiomatoid Fibrous Histiocytoma

    Sabrina Rossi;Kàroly Szuhai;Marije Ijszenga;Hans J Tanke

  • Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.

    Nadège Presneau;Asem Shalaby;Hongtao Ye;Nischalan Pillay

  • Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma

    Arjen H.G. Cleven;Saskia Höcker;Inge Briaire-de Bruijn;Karoly Szuhai

  • Peters Plus Syndrome Is Caused by Mutations in B3GALTL, a Putative Glycosyltransferase

    Saskia A.J. Lesnik Oberstein;Marjolein Kriek;Stefan J. White;Margot E. Kalf

  • Guidelines for molecular karyotyping in constitutional genetic diagnosis.

    Joris Robert Vermeesch;Heike Fiegler;Nicole de Leeuw;Karoly Szuhai

  • Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium

    Anke M. Smits;Linda W. van Laake;Linda W. van Laake;Krista den Ouden;Chantal Schreurs

  • Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities

    Remco Dijkman;Remco van Doorn;Károly Szuhai;Rein Willemze

  • Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients.

    Wilma E. Mesker;Gerrit-Jan Liefers;Jan M. C. Junggeburt;Gabi W. van Pelt

  • Real‐time monitoring of rolling‐circle amplification using a modified molecular beacon design

    Mats Nilsson;Mats Gullberg;Fredrik Dahl;Karoly Szuhai

  • Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone

    Jan H.N. Lindeman;Roeland Hanemaaijer;Adri Mulder;P.D. Sander Dijkstra

Frequent Co-Authors

Pancras C.W. Hogendoorn
Pancras C.W. Hogendoorn Leiden University Medical Center
Judith V.M.G. Bovée
Judith V.M.G. Bovée Leiden University Medical Center
Hans J. Tanke
Hans J. Tanke Leiden University Medical Center
Carla Rosenberg
Carla Rosenberg Universidade de São Paulo
Anton K. Raap
Anton K. Raap Leiden University Medical Center
Cornelis P. Tensen
Cornelis P. Tensen Leiden University Medical Center
Fredrik Mertens
Fredrik Mertens Lund University
Adrienne M. Flanagan
Adrienne M. Flanagan University College London
Rein Willemze
Rein Willemze Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring genetics doesn’t have to follow a traditional path. Today’s learners can take advantage of diverse online education options to jumpstart their careers. For those interested in healthcare administration, studying online medical billing and coding is a practical route that blends healthcare and data management—skills that complement genetic research and services.

Students looking to enter the workforce quickly might consider accelerated colleges, which offer fast-track degree programs, allowing you to complete requirements in much less time. Some schools even provide best online self paced colleges, where you can tailor your learning schedule to fit your needs—perfect for balancing studies with personal or professional obligations.

If cost or application barriers are a concern, look for universities with no application fee. These institutions make it easy to begin your genetic studies without upfront costs. By exploring these flexible degree and career paths, students can find a program that matches their aspirations within or alongside the field of genetics.

Best Scientists Citing Karoly Szuhai

Trending Scientists